Evidence-based·Last reviewed May 30, 2026·How we grade evidence

Bifidobacterium bifidum

Probiotic

Useful mainly for adults with IBS, constipation, or antibiotic-associated diarrhea; infants/children with atopic dermatitis.

Quick decision guide

May help most

Adults with IBS, constipation, or antibiotic-associated diarrhea; infants/children with atopic dermatitis

Common dosing range

1–10 billion CFU/day

When to expect effects

4–8 weeks for digestive effects

Watch out for

Immunocompromised individuals should consult a physician before using live probiotic supplements

What is it

Bifidobacterium bifidum is a probiotic bacterium found in the human gut, especially in breastfed infants and healthy adults. It is widely used in probiotic supplements for digestive, immune, and allergic applications, often combined with other Bifidobacterium and Lactobacillus strains.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You have IBS and want a specific strain with trial evidence (MIMBb75)
You are experiencing constipation and have not yet tried probiotic support
You or your child have mild atopic dermatitis
You are on or recently completed antibiotics and want to restore gut flora

Probably skip if…

You are severely immunocompromised
You are critically ill or have a central venous catheter
You expect results in the first few days (allow 4–8 weeks)

Evidence at a glance

irritable bowel syndrome

Good Evidence
Effect
Significant reduction in global IBS symptom score vs. placebo in strain-specific trials
Best fit
Adults with diagnosed IBS (all subtypes studied)
Time
4–8 weeks

constipation

Limited Evidence
Effect
Modest increase in stool frequency and consistency in small trials
Best fit
Adults with functional constipation
Time
2–4 weeks

Evidence for 2 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

irritable bowel syndrome

Disease adjunct
Good Evidence

Strain MIMBb75 (1 billion CFU/day) has been studied in two RCTs showing significant reductions in IBS Global Assessment scores, abdominal pain, and bloating compared to placebo. Effects are strain-specific—evidence for MIMBb75 does not extend automatically to all B. bifidum products. Trials also show improvement in quality of life scores.

Effect size
Significant reduction in global IBS symptom score vs. placebo in strain-specific trials
Time to effect
4–8 weeks
Best fit
Adults with diagnosed IBS (all subtypes studied)
Less likely
People with IBS-D who respond better to other interventions (FODMAP diet, rifaximin)

Bottom line: B. bifidum strain MIMBb75 has B-level evidence for IBS symptom relief; other strains have less data.

SourceAndresen et al., 2020 — PubMedGuglielmetti et al., 2011 — PubMed

constipation

Supplement benefit
Limited Evidence

Small RCTs of B. bifidum-containing multi-strain probiotic blends show modest improvement in stool frequency and consistency in functional constipation. Isolating the B. bifidum contribution from other probiotic strains in blended products is not straightforward. Effect sizes are small.

Effect size
Modest increase in stool frequency and consistency in small trials
Time to effect
2–4 weeks
Best fit
Adults with functional constipation

Bottom line: B. bifidum may modestly improve constipation outcomes; evidence is limited and often from multi-strain studies.

SourceWang et al., 2022 — PubMedIkeda et al., 2026 — PMC

How it works

B. bifidum colonizes the colon and ferments complex carbohydrates and human milk oligosaccharides (HMOs), producing acetate and lactate as primary fermentation products. These short-chain fatty acids lower colonic pH and create an environment less favorable for pathogenic bacteria, while also providing energy to colonocytes and supporting barrier function. B. bifidum interacts directly with intestinal epithelial cells via specific surface molecules and stimulates the gut-associated immune system. Some strains produce extracellular polysaccharides that may modulate immune responses, supporting a more balanced inflammatory profile. The species is among the few bacteria capable of efficiently breaking down certain HMOs, which is why it is prominent in the breastfed infant gut. Strain-level effects vary. Strain MIMBb75 has been studied for IBS. Strain Bb-06 is common in multi-strain supplement blends. Strain BB-02 has been studied for infant applications. Research on one B. bifidum strain does not necessarily apply to others.

How to take it

1. Typical dose
1–10 billion CFU/day
2. Timing
With a small meal, at the same time daily
3. With food
With food may improve bacterial survival through the stomach
4. How long to try
4–8 weeks minimum to assess digestive benefit; ongoing for chronic IBS or skin conditions

What to track

IBS symptom severity and stool frequency
Skin severity score if for atopic dermatitis
Diarrhea frequency if post-antibiotic
Any adverse GI reactions in first week

3 commercial forms

Compare the main delivery options and what they’re best suited for.

B. bifidum MIMBb75

Most-studied strain for IBS applications. Some trials show benefit even with heat-killed cells, suggesting non-viable cell components may be active.

Studied as both viable and heat-inactivated

B. bifidum Bb-06

Used in multi-strain adult probiotic formulations.

Common in commercial blends

B. bifidum BB-02

Studied in pediatric protocols, often combined with other Bifidobacterium strains.

Used in infant applications

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Mild gas or bloating in the first few days of use

Serious risks

  • Rare bacteremia in severely immunocompromised or critically ill patients

Who should avoid it

  • Severely immunocompromised individuals
  • Critically ill patients with central venous catheters
  • Premature infants without specialist supervision

Pregnancy & breastfeeding

B. bifidum is generally considered safe in pregnancy; no safety concerns identified from food-form use; supplement use is generally well tolerated.

Interactions

antibioticsMinor

Antibiotics suppress live probiotic bacteria; separate doses by at least 2 hours; resume full probiotic dose after course

immunosuppressive medicationsMinor

May theoretically increase risk of bacterial translocation; discuss with prescriber

Food sources

Yogurts (some brands with Bifidobacterium added)

Amount
Variable; B. bifidum specifically less common than B. animalis
%DV
—

Kefir

Amount
Multi-strain fermented milk; variable Bifidobacterium content
%DV
—

Human breast milk (natural source for infants)

Amount
Natural transmission
%DV
—

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for…

Strain designation stated (e.g., MIMBb75, Bb-06)
CFU count guaranteed through expiration
Refrigeration requirements stated if applicable
Prebiotic (FOS, GOS) included if synbiotic formula

Be skeptical of…

Cures IBD or Crohn's disease
Replaces antibiotics
Guaranteed colonization after supplementation stops

Frequently asked questions

How is B. bifidum different from B. longum?⌄

They are separate species with different metabolic profiles and somewhat different documented uses. Both are common in the healthy adult colon, but they break down different substrates and have been studied for somewhat different applications.

Does heat-killed B. bifidum work?⌄

Some trials of heat-inactivated B. bifidum MIMBb75 in IBS show benefit similar to viable cells, suggesting cell-wall components may contribute to effects independent of live colonization.

Can I take B. bifidum with prebiotic fiber?⌄

Yes. Combining B. bifidum with prebiotics like FOS, GOS, or inulin may support its growth and persistence in the gut. Many 'synbiotic' supplements combine both.

How long does B. bifidum take to work?⌄

For IBS trials, effects typically emerge over 4 to 8 weeks. For acute conditions like antibiotic-associated diarrhea, effects appear sooner.

Is B. bifidum safe for children?⌄

B. bifidum is generally well tolerated in children and is included in many pediatric probiotic products. Discuss with your pediatrician for specific applications.

References by claim

irritable bowel syndrome

Andresen et al., 2020 — PubMed (2020) link

Guglielmetti et al., 2011 — PubMed (2011) link

constipation

Wang et al., 2022 — PubMed (2022) link

Ikeda et al., 2026 — PMC (2026) link

Track Bifidobacterium bifidum with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.